Insights

Q2 2026 Drug Updates: New FDA Approvals, Generics and Biosimilars to Watch 

Learn More

Your PBM Contract Has Fine Print. The Fine Print Is Where the Money Is.

Learn More

What Plan Sponsors Need to Know About HIV Treatment, PrEP and Pharmacy Costs

Learn More

Everyone’s Talking About Pharmacogenomics. The Hard Part Is Making It Work 

Learn More

GLP-1 Market Update: Oral Drugs, New Formulations, Pipeline Activity, and Pricing Shifts 

Learn More

International Drug Sourcing Is Under Scrutiny. What Employers Should Understand Before Adopting It 

Learn More

Direct-to-Consumer (DTC) Prescription Drug Programs 

Learn More

Filter Insights:

Join our newsletter to stay up to date on market trends.

By subscribing you agree to with our Privacy Policy and provide consent to receive updates from our company.

Latest Insights

Q2 2026 Drug Updates: New FDA Approvals, Generics and Biosimilars to Watch 

AlignRx is Now Navion